Jiuru Sun

Title: The Innovative Contributions of Jiuru Sun

Introduction

Jiuru Sun is a notable inventor based in Box Hill North, Australia. He has made significant contributions to the field of biotechnology, particularly in the development of anti-angiogenesis therapies. His work focuses on creating innovative solutions to combat diseases related to vascular growth.

Latest Patents

Jiuru Sun holds a patent for an anti-angiogenesis fusion protein. This novel protein combines a chimeric vascular endothelial cell growth factor (VEGF) receptor or a fragment thereof with a multimerizing component. The invention boasts superior binding capacity with human VEGF and placental growth factor (PIGF). The fusion protein is characterized by improved stability, a prolonged half-life, and the ability to form multivalent interactions with VEGF. This innovation has potential applications in anti-angiogenesis, treating VEGF-related diseases, and inhibiting tumor growth.

Career Highlights

Jiuru Sun is associated with Genor Biopharma Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, contributing to the understanding and treatment of complex diseases.

Collaborations

Some of his notable coworkers include Joe Zhou and Jianyang Zhao, who collaborate with him on various projects within the company.

Conclusion

Jiuru Sun's innovative work in developing anti-angiogenesis fusion proteins highlights his significant contributions to biotechnology. His research not only advances scientific knowledge but also offers hope for effective treatments against serious health conditions.